The SickKids Cancer Sequencing Program (KiCS) is a research study at the Hospital for Sick Children (SickKids) designed to learn how to best use a new kind of genetic test, called next generation sequencing (NGS) in clinical cancer care. The test will be used to get information about the genome of a child's tumour/cancer and a child's healthy cells. By doing this, researchers want to know if this new test can help: 

  1. Better characterize a child's tumour and identify its unique ‘fingerprint’
  2. Use this information to identify specific medications/treatment options for a child’s tumour 
  3. Use this information to follow a tumour’s response to treatment
  4. Gain information about a child’s prognosis
  5. Understand the cause of a child’s cancer – that is, whether a child’s tumour developed ‘by chance’, as is often the case, or if they have an underlying tendency, or predisposition for tumour development
KICS cover.jpg

This study is being led by Dr. David Malkin and Dr. Adam Shlien at The Hospital for Sick Children (SickKids). The current funder of this research is the Garron Family Cancer Centre.
Dr. David Malkin, Dr. Adam Shlien and the other research team members have no conflict of interest to declare.

For more information, please email